Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bicara Therapeutics

Clinical trials sponsored by Bicara Therapeutics, explained in plain language.

Bicara Therapeutics BCAX NASDAQ

Clinical-stage biotech developing bifunctional antibodies for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New combo therapy aims to shrink head and neck tumors that resist standard treatment

Disease control Recruiting now

This study tests whether adding an experimental drug called ficerafusp alfa to the immunotherapy pembrolizumab (Keytruda) works better than pembrolizumab alone for people with PD-L1-positive head and neck cancer that has spread or returned. About 650 adults will be randomly assig…

Phase: PHASE2, PHASE3 • Sponsor: Bicara Therapeutics • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC